Go Pro

Swayampakula Ramakanth Analyst Performance

Managing Directo at HC Wainwright

Swayampakula Ramakanth is a stock analyst at HC Wainwright focused in the healthcare sector, covering 78 publicly traded companies. Over the past year, Swayampakula Ramakanth has issued 118 stock ratings, including strong buy, buy, and hold recommendations. While full access to Swayampakula Ramakanth's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Swayampakula Ramakanth's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
465 Last 11 Years
Buy Recommendations
95.25% 441 Buy Ratings
Companies Covered
78 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.6%3 ratings
Buy94.6%438 ratings
Hold4.8%22 ratings
Sell0.0%0 ratings

Out of 463 total stock ratings issued by Swayampakula Ramakanth at HC Wainwright, the majority (94.6%) have been Buy recommendations, followed by 4.8% Hold and 0.6% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
89.7% of companies on NASDAQ
70 companies
NYSEAMERICAN
3.8% of companies on NYSEAMERICAN
3 companies
NYSE
2.6% of companies on NYSE
2 companies
OTCMKTS
2.6% of companies on OTCMKTS
2 companies
TSE
1.3% of companies on TSE
1 company

Swayampakula Ramakanth, an analyst at HC Wainwright, currently covers 78 companies listed on NASDAQ, NYSEAMERICAN, NYSE, OTCMKTS and TSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
76 companies
97.4%
Technology
1 company
1.3%
Miscellaneous
1 company
1.3%

Swayampakula Ramakanth of HC Wainwright specializes in stock coverage within the Healthcare sector, with additional focus on Technology and companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
38 companies
48.7%
PHARMACEUTICALS
17 companies
21.8%
HEALTHCARE EQUIPMENT & SUPPLIES
14 companies
17.9%
LIFE SCIENCES TOOLS & SERVICES
5 companies
6.4%
HEALTHCARE TECHNOLOGY
1 company
1.3%
IT SERVICES
1 company
1.3%
LABORATORY APPARATUS & FURNITURE
1 company
1.3%
Miscellaneous
1 company
1.3%

About Swayampakula Ramakanth

Dr. Ramakanth is a Managing Director of Equity Research at H.C. Wainwright whose research focuses on the healthcare sector. Dr. Ramakanth’s research covers companies operating in oncology, wound health, medical devices, spine health and animal health. Dr. Ramakanth possesses over ten years of experience as a Life Sciences Equity Analyst as well as seven years of biotechnology industry experience. Prior to joining H.C. Wainwright, Dr. Ramakanth worked as a Junior Analyst at both Jefferies and Merrill Lynch covering large cap pharmaceuticals. Dr. Ramakanth was also a Junior Analyst at both First Albany and Rodman & Renshaw where he focused on biotechnology companies. Dr. Ramakanth also conducted bench research and directed a preclinical drug development group at Regeneron Pharmaceuticals, Inc. Dr. Ramakanth presented at various regional and international conferences and published in several peer-reviewed journals. Dr. Ramakanth’s educational background includes a Ph.D. in Pharmacology/Toxicology from the University of Utah, an MBA from Rutgers University, an M.S. in Pharmaceutics from Auburn University, and a B. Pharm (Hons.) from BITS, India. Dr. Ramakanth also held a post-doctoral fellowship at the University of Texas MD Anderson Cancer Center.
Follow on LinkedIn

Swayampakula Ramakanth's Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
9/10/2026Boost Price Target$3.38$8.00Buy
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
9/9/2026Initiated Coverage$4.73$11.00Buy
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
9/9/2026Initiated Coverage$4.76$11.00Buy
FOCL
FocalTherics
8/25/2026Reiterated Rating$4.18$10.00Buy
Lifeward Ltd. stock logo
LFWD
Lifeward
8/21/2026Reiterated Rating$7.33$10.00Buy
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
8/19/2026Reiterated Rating$0.57Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
8/18/2026Reiterated Rating$0.99Buy
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
8/18/2026Reiterated Rating$3.02$7.00Buy
Intensity Therapeutics Inc. stock logo
INTS
Intensity Therapeutics
8/18/2026Boost Price Target$4.32$7.00Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
8/14/2026Boost Price Target$40.80$70.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
8/14/2026Reiterated Rating$92.44$155.00Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
8/11/2026Boost Price Target$43.67$65.00Buy
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
8/10/2026Boost Price Target$2.20$7.00Buy
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
8/7/2026Reiterated Rating$15.47$32.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
8/6/2026Lower Price Target$105.79$140.00Buy
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
8/6/2026Boost Price Target$112.50$158.00Buy
Precigen, Inc. stock logo
PGEN
Precigen
8/5/2026Boost Price Target$6.53$18.00Buy
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
8/5/2026Boost Price Target$6.84$14.00Buy
Precigen, Inc. stock logo
PGEN
Precigen
8/3/2026Reiterated Rating$6.27$14.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
7/30/2026Boost Price Target$92.95$165.00Buy
Vericel Corporation stock logo
VCEL
Vericel
7/28/2026Reiterated Rating$45.32$70.00Buy
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
7/20/2026Reiterated Rating$1.46Buy
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
7/20/2026Initiated Coverage$5.87$12.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
7/15/2026Boost Price Target$111.05$155.00Buy
Evotec AG stock logo
EVO
Evotec
7/15/2026Lower Price Target$2.14$4.00Buy
Can-Fite BioPharma Ltd. stock logo
CANF
Can-Fite BioPharma
7/2/2026Reiterated Rating$4.63$8.00Buy
Unicycive Therapeutics, Inc. stock logo
UNCY
Unicycive Therapeutics
6/30/2026Lower Price Target$4.70$15.00Buy
Absci Corporation stock logo
ABSI
Absci
6/25/2026Boost Price Target$10.08$16.00Buy
Conexeu Sciences Inc. stock logo
CNXU
Conexeu Sciences
6/22/2026Initiated Coverage$13.28$20.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
6/15/2026Reiterated Rating$99.35Buy
Humacyte, Inc. stock logo
HUMA
Humacyte
6/11/2026Boost Price Target$1.04$4.00Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
6/10/2026Reiterated Rating$2.01Buy
Nuvalent, Inc. stock logo
NUVL
Nuvalent
6/9/2026Downgrade$122.82$124.00Neutral
IN8bio, Inc. stock logo
INAB
IN8bio
6/4/2026Reiterated Rating$1.54Buy
Celcuity, Inc. stock logo
CELC
Celcuity
6/3/2026Lower Price Target$91.42$145.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
6/2/2026Boost Price Target$70.44$95.00Buy
MediWound Ltd. stock logo
MDWD
MediWound
5/28/2026Reiterated Rating$14.33$36.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
5/28/2026Boost Price Target$66.65$95.00Buy
Precigen, Inc. stock logo
PGEN
Precigen
5/28/2026Boost Price Target$4.40$14.00Buy
Humacyte, Inc. stock logo
HUMA
Humacyte
5/26/2026Reiterated Rating$1.09$3.00Buy
Earth's biggest energy source: near Grand Canyon (Ad)

The largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - and much of it sits beneath the desert near the Grand Canyon. A drilling crew just hit the DOE's 2035 targets twelve years early, with costs down 50% in 18 months. Google signed on, Gates invested, and the Pentagon made it a priority. One company has been quietly building this infrastructure for sixty years.tc pixel

See the company sitting on the biggest energy source on Earth
MindWalk Holdings Corp. stock logo
HYFT
MindWalk
5/19/2026Reiterated Rating$1.24$5.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
5/18/2026Boost Price Target$137.68$185.00Buy
Citius Pharmaceuticals, Inc. stock logo
CTXR
Citius Pharmaceuticals
5/18/2026Reiterated Rating$0.55$4.00Buy
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
5/18/2026Reiterated Rating$14.31$31.00Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
5/18/2026Reiterated Rating$2.43$15.00Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
5/15/2026Boost Price Target$29.40$57.00Buy
Precigen, Inc. stock logo
PGEN
Precigen
5/14/2026Boost Price Target$4.15$11.00Buy
Can-Fite BioPharma Ltd. stock logo
CANF
Can-Fite BioPharma
5/12/2026Set Price Target$3.36$5.00Buy
Vericel Corporation stock logo
VCEL
Vericel
5/8/2026Reiterated Rating$35.13$64.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
5/7/2026Set Price Target$101.07$185.00
BioStem Technologies, Inc. stock logo
BSEM
BioStem Technologies
5/6/2026Upgrade$4.18Strong-Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
5/4/2026Boost Price Target$51.42$75.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
5/4/2026Boost Price Target$108.37$175.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
4/27/2026Boost Price Target$93.03$150.00Buy
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
4/24/2026Reiterated Rating$4.25$16.00Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
4/22/2026Reiterated Rating$2.27$15.00Buy
Nuvalent, Inc. stock logo
NUVL
Nuvalent
4/21/2026Reiterated Rating$108.24$155.00Buy
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
4/15/2026Lower Price Target$15.87$31.00Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
4/13/2026Lower Price Target$1.72$15.00Buy
FOCL
FocalTherics
4/9/2026Lower Price Target$3.32$10.00Buy
RenovoRx, Inc. stock logo
RNXT
RenovoRx
4/8/2026Reiterated Rating$0.94$3.00Buy
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
4/7/2026Reiterated Rating$1.35$5.00Buy
Precigen, Inc. stock logo
PGEN
Precigen
3/26/2026Boost Price Target$3.10$10.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
3/25/2026Boost Price Target$1.92$10.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
3/25/2026Lower Price Target$40.78$60.00Buy
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
3/24/2026Reiterated Rating$1.42$7.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
3/23/2026Reiterated Rating$88.51$130.00Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
3/20/2026Boost Price Target$22.67$52.00Buy
Lifeward Ltd. stock logo
LFWD
Lifeward
3/19/2026Boost Price Target$6.72$10.00Buy
IN8bio, Inc. stock logo
INAB
IN8bio
3/13/2026Reiterated Rating$1.91Buy
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
3/10/2026Reiterated Rating$2.13$4.00Buy
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
3/9/2026Reiterated Rating$3.22$16.00Buy
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
3/9/2026Boost Price Target$77.56$130.00Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
3/2/2026Boost Price Target$16.99$37.00Buy
Vericel Corporation stock logo
VCEL
Vericel
2/27/2026Boost Price Target$36.13$64.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
2/20/2026Lower Price Target$34.24$67.00Buy
Verastem, Inc. stock logo
VSTM
Verastem
2/4/2026Initiated Coverage$6.30$18.00Buy
electroCore, Inc. stock logo
ECOR
electroCore
1/26/2026Lower Price Target$7.47$18.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
1/26/2026Boost Price Target$94.29$130.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
1/22/2026Boost Price Target$41.47$105.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
1/13/2026Reiterated Rating$89.50$102.00Buy
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
1/9/2026Reiterated Rating$10.45$30.00Buy
Compugen Ltd. stock logo
CGEN
Compugen
1/7/2026Initiated Coverage$1.55$4.00Buy
Compugen Ltd. stock logo
CGEN
Compugen
1/7/2026Initiated Coverage$1.72$4.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
1/2/2026Lower Price Target$34.80$90.00Buy
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
12/31/2025Downgrade$10.61Neutral
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
12/19/2025Boost Price Target$1.73$7.00Buy
Absci Corporation stock logo
ABSI
Absci
12/17/2025Boost Price Target$3.54$8.00Buy
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
12/2/2025Lower Price Target$33.99$45.00Buy
Humacyte, Inc. stock logo
HUMA
Humacyte
12/1/2025Reiterated Rating$1.36$3.00Buy
My ‘one day’ retirement secret (Ad)

TradeSmith's AI research team, backed by a $17 million investment and led by a former NSA codebreaker, built a tool that narrows the market down to just five stocks a month. In backtesting, that five-stock approach outpaced the broader market and big tech names like Microsoft and Amazon. More than 300,000 people have already viewed the demonstration. No daily chart-watching required, just a monthly check-in on five selected stocks.tc pixel

Watch the free demo and see the five stocks now
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
11/25/2025Reiterated Rating$31.53$70.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
11/25/2025Reiterated Rating$77.71$145.00Buy
MediWound Ltd. stock logo
MDWD
MediWound
11/21/2025Reiterated Rating$16.86$36.00Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
11/19/2025Reiterated Rating$6.10$20.00Buy
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
11/18/2025Set Price Target$4.18$6.00Buy
Lifeward Ltd. stock logo
LFWD
Lifeward
11/18/2025Lower Price Target$7.14$54.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
11/17/2025Reiterated Rating$92.68$94.00Neutral
Nuvalent, Inc. stock logo
NUVL
Nuvalent
11/17/2025Boost Price Target$112.06$155.00Buy
Precigen, Inc. stock logo
PGEN
Precigen
11/14/2025Boost Price Target$3.86$9.00Buy
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
11/14/2025Lower Price Target$9.75$32.00Buy
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
11/10/2025Boost Price Target$36.28$47.00Buy
Personalis, Inc. stock logo
PSNL
Personalis
11/6/2025Boost Price Target$7.66$10.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
11/5/2025Boost Price Target$70.97$81.00Buy
Can-Fite BioPharma Ltd. stock logo
CANF
Can-Fite BioPharma
11/4/2025Reiterated Rating$8.24$50.00Buy
Unicycive Therapeutics, Inc. stock logo
UNCY
Unicycive Therapeutics
10/29/2025Reiterated Rating$4.72$22.00Buy
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
10/29/2025Set Price Target$2.10$5.00Buy
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
10/29/2025Boost Price Target$25.28$52.00Buy
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
10/29/2025Upgrade$2.00Strong-Buy
Dyadic International Inc. stock logo
DYAI
Dyadic International
10/23/2025Initiated Coverage$1.10$3.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
10/22/2025Boost Price Target$65.50$77.00Buy
Verastem, Inc. stock logo
VSTM
Verastem
10/21/2025Reiterated Rating$8.02$14.00Buy
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
10/20/2025Set Price Target$11.42$30.00Buy
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
10/20/2025Reiterated Rating$6.79$16.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
10/20/2025Reiterated Rating$79.49$145.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
10/10/2025Reiterated Rating$88.36$145.00Buy
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
9/25/2025Boost Price Target$4.00$16.00Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
9/23/2025Reiterated Rating$7.09$20.00Buy
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
9/18/2025Downgrade$2.05Neutral
Personalis, Inc. stock logo
PSNL
Personalis
9/8/2025Reiterated Rating$5.24$8.50Buy
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
9/8/2025Reiterated Rating$26.50$40.00Buy
CollPlant Biotechnologies Ltd. Sponsored ADR stock logo
CLGN
CollPlant Biotechnologies
8/21/2025Reiterated Rating$19.70$110.00Buy
Precigen, Inc. stock logo
PGEN
Precigen
8/19/2025Reiterated Rating$2.95$8.50Buy
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
8/19/2025Reiterated Rating$1.24$5.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
8/18/2025Boost Price Target$51.79$66.00Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
8/18/2025Reiterated Rating$8.12$20.00Buy
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
8/14/2025Reiterated Rating$1.23Neutral
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
8/14/2025Reiterated Rating$40.40$60.00Buy
X4 Pharmaceuticals, Inc. stock logo
XFOR
X4 Pharmaceuticals
8/13/2025Set Price Target$2.58$3.50Buy
Precigen, Inc. stock logo
PGEN
Precigen
8/13/2025Reiterated Rating$1.80$6.00Buy
Humacyte, Inc. stock logo
HUMA
Humacyte
8/12/2025Lower Price Target$1.75$3.00Buy
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
8/7/2025Boost Price Target$53.39$80.00Buy
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
8/7/2025Boost Price Target$10.64$31.00Buy
Personalis, Inc. stock logo
PSNL
Personalis
8/6/2025Lower Price Target$5.64$8.50Buy
Celcuity, Inc. stock logo
CELC
Celcuity
7/28/2025Boost Price Target$39.34$50.00Buy
Aethlon Medical, Inc. stock logo
AEMD
Aethlon Medical
7/7/2025Upgrade$1.27Neutral
Ocugen, Inc. stock logo
OCGN
Ocugen
6/24/2025Reiterated Rating$0.98$7.00Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
5/29/2025Reiterated Rating$20.08$35.00Buy
Unicycive Therapeutics, Inc. stock logo
UNCY
Unicycive Therapeutics
5/27/2025Upgrade$5.53$90.00Strong-Buy
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
5/23/2025Reiterated Rating$16.15$29.00Buy
MediWound Ltd. stock logo
MDWD
MediWound
5/22/2025Set Price Target$19.89$31.00Buy
“Elon’s nightmare” could fund your retirement (Ad)

Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg terminal, says a new micro cluster AI technology could render today's data centers, including Elon Musk's Colossus in Tennessee, obsolete for major breakthroughs. These next generation centers use 99 percent less space, electricity and water, yet Chaikin's research shows they could be more than a trillion times more powerful than the top data center on earth today, potentially cutting AI breakthrough timelines from five years to five days.tc pixel

See Chaikin's full research and the company name here
Mirum Pharmaceuticals, Inc. stock logo
MIRM
Mirum Pharmaceuticals
5/19/2025Reiterated Rating$45.01$73.00Buy
Celcuity, Inc. stock logo
CELC
Celcuity
5/19/2025Reiterated Rating$10.61$27.00Buy
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
5/19/2025Reiterated Rating$1.21$5.00Buy
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
5/19/2025Reiterated Rating$1.41$5.50Buy
Affimed stock logo
AFMD
Affimed
5/14/2025Downgrade$0.11Neutral
Humacyte, Inc. stock logo
HUMA
Humacyte
5/14/2025Initiated Coverage$1.93$4.00Buy
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
5/13/2025Reiterated Rating$20.08$40.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
5/12/2025Lower Price Target$0.70$7.00Buy
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
5/9/2025Reiterated Rating$0.16Neutral
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
5/9/2025Lower Price Target$0.46$2.00Buy
Personalis, Inc. stock logo
PSNL
Personalis
5/7/2025Boost Price Target$4.00$9.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
5/6/2025Lower Price Target$73.94$145.00Buy
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
5/6/2025Lower Price Target$7.15$60.00Buy
X4 Pharmaceuticals, Inc. stock logo
XFOR
X4 Pharmaceuticals
5/2/2025Boost Price Target$3.75$7.00Buy
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
4/24/2025Reiterated Rating$2.00$11.00Buy
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
4/2/2025Reiterated Rating$1.66$14.00Buy
Spectral AI, Inc. stock logo
MDAI
Spectral AI
4/2/2025Reiterated Rating$1.20$3.50Buy
Celcuity, Inc. stock logo
CELC
Celcuity
4/1/2025Reiterated Rating$10.11$27.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
3/31/2025Boost Price Target$100.43$150.00Buy
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
3/28/2025Reiterated Rating$1.97$11.50Buy
FOCL
FocalTherics
3/28/2025Reiterated Rating$2.22$19.00Buy
RenovoRx, Inc. stock logo
RNXT
RenovoRx
3/27/2025Initiated Coverage$1.02$3.00Buy
X4 Pharmaceuticals, Inc. stock logo
XFOR
X4 Pharmaceuticals
3/27/2025Reiterated Rating$8.08$45.00Buy
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
3/21/2025Lower Price Target$17.04$260.00Buy
MediWound Ltd. stock logo
MDWD
MediWound
3/20/2025Reiterated Rating$18.28$25.00Buy
Precigen, Inc. stock logo
PGEN
Precigen
3/20/2025Reiterated Rating$1.79$6.00Buy
Absci Corporation stock logo
ABSI
Absci
3/19/2025Reiterated Rating$3.08$7.00Buy
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
3/19/2025Reiterated Rating$1.06$5.00Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
3/19/2025Reiterated Rating$14.68$33.00Buy
Spectral AI, Inc. stock logo
MDAI
Spectral AI
3/18/2025Reiterated Rating$1.76$3.50Buy
Actuate Therapeutics, Inc. stock logo
ACTU
Actuate Therapeutics
3/17/2025Initiated Coverage$7.25$20.00Buy
IN8bio, Inc. stock logo
INAB
IN8bio
3/14/2025Lower Price Target$6.79$180.00Buy
electroCore, Inc. stock logo
ECOR
electroCore
3/13/2025Reiterated Rating$13.00$25.00Buy
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
3/12/2025Reiterated Rating$23.38$40.00Buy
Lifeward Ltd. stock logo
LFWD
Lifeward
3/11/2025Reiterated Rating$15.72$156.00Buy
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
3/7/2025Boost Price Target$13.22$24.00Buy
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
3/7/2025Reiterated Rating$1.31$5.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
3/6/2025Reiterated Rating$0.57$8.00Buy
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
3/4/2025Reiterated Rating$7.23$135.00Buy
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
3/3/2025Reiterated Rating$32.89$70.00Buy
Personalis, Inc. stock logo
PSNL
Personalis
2/28/2025Reiterated Rating$4.24$8.00Buy
Vericel Corporation stock logo
VCEL
Vericel
2/28/2025Reiterated Rating$49.62$60.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
2/27/2025Reiterated Rating$63.37$115.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
2/26/2025Reiterated Rating$11.10$33.00Buy
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
2/20/2025Reiterated Rating$2.55$14.00Buy
Lifeward Ltd. stock logo
LFWD
Lifeward
2/20/2025Reiterated Rating$22.08$156.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
2/13/2025Boost Price Target$0.66$8.00Buy
IN8bio, Inc. stock logo
INAB
IN8bio
2/12/2025Reiterated Rating$9.20$240.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
2/7/2025Reiterated Rating$68.04$80.00Buy
X4 Pharmaceuticals, Inc. stock logo
XFOR
X4 Pharmaceuticals
2/7/2025Reiterated Rating$16.50$45.00Buy
Gold led me to Mount Rushmore (Ad)

A small miner just hit on gold in the hills surrounding Mount Rushmore, thanks to a breakthrough new technology. This could be one of the biggest gold finds since the 1870s, yet the stock still trades around 6 dollars. BlackRock and Vanguard have been quietly loading up on shares while most investors have missed the story. The same technology is unlocking hidden resource wealth across America, driving stocks up 227 percent, 378 percent, and even 773 percent.tc pixel

Watch the free video and get the stock name now
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
2/6/2025Reiterated Rating$1.95$11.50Buy
Evaxion A/S - Sponsored ADR stock logo
EVAX
Evaxion A/S
2/3/2025Reiterated Rating$2.45$14.00Buy
Cypherpunk Technologies stock logo
CYPH
Cypherpunk Technologies
1/29/2025Downgrade$0.65Neutral
Personalis, Inc. stock logo
PSNL
Personalis
1/27/2025Lower Price Target$6.12$8.00Buy
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
1/24/2025Lower Price Target$1.63$5.00Buy
Precigen, Inc. stock logo
PGEN
Precigen
1/23/2025Reiterated Rating$1.13$6.00Buy
Eton Pharmaceuticals, Inc. stock logo
ETON
Eton Pharmaceuticals
1/23/2025Boost Price Target$15.77$33.00Buy
Innate Pharma S.A. Sponsored ADR stock logo
IPHA
Innate Pharma
1/17/2025Reiterated Rating$1.67$11.50Buy
Absci Corporation stock logo
ABSI
Absci
1/17/2025Reiterated Rating$2.80$7.00Buy
Cypherpunk Technologies stock logo
CYPH
Cypherpunk Technologies
1/16/2025Reiterated Rating$3.25$5.50Buy
Vericel Corporation stock logo
VCEL
Vericel
1/15/2025Reiterated Rating$58.67$60.00Buy
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
1/14/2025Reiterated Rating$1.93$5.50Buy
ChronoScale Corporation Common Stock stock logo
CHRN
ChronoScale Corporation Common Stock
1/14/2025Reiterated Rating$10.68$135.00Buy
X4 Pharmaceuticals, Inc. stock logo
XFOR
X4 Pharmaceuticals
1/14/2025Reiterated Rating$16.96$45.00Buy
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
1/14/2025Reiterated Rating$12.79$22.00Buy
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
1/13/2025Reiterated Rating$14.68$33.00Buy
Ocugen, Inc. stock logo
OCGN
Ocugen
1/13/2025Reiterated Rating$0.75$7.00Buy
MediWound Ltd. stock logo
MDWD
MediWound
1/10/2025Reiterated Rating$16.01$25.00Buy
Absci Corporation stock logo
ABSI
Absci
1/8/2025Reiterated Rating$3.27$7.00Buy
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
10/18/2024Boost Price Target$47.17$80.00Buy